Viridian Therapeutics, Inc./DE (VRDN)

SEC filing

Viridian Therapeutics, Inc./DE

VRDN · CIK 1590750

4 · Aug 18, 2026 · Chief Medical Officer Tripuraneni Radhika exercised options for 80K shares

Chief Medical Officer Tripuraneni Radhika exercised options for 80K shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.